Fabtech Technologies Limited — Regulatory Filings 2025

Nov 4, 2025

==> picture [597 x 93] intentionally omitted <==

Date: November 04, 2025

To,

National Stock Exchange of India Limited BSE Limited Exchange Plaza, C-1, Block G, Listing Department Bandra Kurla Complex, Floor 25, P J Towers, Bandra (East), Mumbai – 400051 Dalal Street, Mumbai – 400001 Maharashtra, India. Maharashtra, India. Symbol: FABTECH Scrip Code: 544558

Dear Sir/Madam,

Sub: Intimation under Regulation 30 of the SEBI (Listing Obligation and Disclosure – Requirements) Regulations, 2015 Intimation of Order/Contract

Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (“Listing Regulation”), this is to inform you that the Company has secured an order/contract with One of the upcoming Veterinary manufacturing Companies in the North African Region which will be Eu GMP certified and to export to EU and neighbouring African countries.

Owing to confidentiality obligations, the name of the customer cannot be disclosed.

The details are required under Regulation 30 of the Listing Regulations read with SEBI/HO/CFD/PoD2/CIR/P/0155 dated November 11, 2024 is attached herewith as “ Annexure A ”.

Thank you.

Yours faithfully, For Fabtech Technologies Limited

HEMANT Digitally signed by HEMANT MOHAN MOHAN ANAVKAR Date: 2025.11.04 ANAVKAR 19:22:34 +05'30'

---

Hemant Mohan Anavkar Executive Director DIN: 00150776

==> picture [597 x 78] intentionally omitted <==

==> picture [597 x 93] intentionally omitted <==

Annexure A

Sr. No.	Particulars	Details
1.	Name of the entity awarding the order(s)/contract(s)	One of the upcoming Veterinary manufacturing Companies in the North African Region which will be Eu GMP certified and to export to EU and neighbouring African countries. (The Customer’s name is withheld due to confidentialityreasons)
2.	Date of bagging/receivingof order(s)/contract(s)	November 03,2025
3.	Significant terms and conditions of order(s)/contract(s) awarded in brief	As per standard industry terms & conditions
4.	Whether order(s)/ contract(s) have been awarded by domestic/international entity	International Entity
5.	Nature of order(s) / contract(s)	To Build Next-Generation Veterinary Formulations Facilityin North Africa.
6.	Whether domestic or international	International
7.	Time period by which the order(s)/contract(s) is to be executed	The order is estimated to be executed by1st Quarter of 2027.
8.	Broad consideration or size of the order(s)/contract(s)	Order Price Ranges from Rs. 49 Crores to Rs. 52 Crores (exclusive of all taxes and levies)
9.	Whether the promoter/ promoter group / group companies have any interest in the entity that awarded the order(s)/contract(s)? If yes, nature of interest and details thereof	Not Applicable
10.	whether the order(s)/contract(s) would fall within related party transactions? If yes, whether the same is done at “arm’s length”	Not Applicable

==> picture [597 x 78] intentionally omitted <==